Pattern of recurrence in endometrial cancer. The murderer always returns to the scene of the crime
© 2024 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved..
BACKGROUND: Endometrial cancer recurrence occurs in about 18 % of patients. This study aims to analyze the pattern recurrence of endometrial cancer and the relationship between the initial site of primary disease and the relapse site in patients undergoing surgical treatment.
METHODS: We retrospectively reviewed all surgically treated patients with endometrial cancer selecting those with recurrence. We defined primary site disease as uterus, lymph nodes, or peritoneum according to pathology analysis of the surgical specimen. The site of recurrence was defined as vaginal cuff, lymph nodes, peritoneum, and parenchymatous organs. Our primary endpoint was to correlate the site of initial disease with the site of recurrence.
RESULTS: The study enrolled 1416 patients. The overall recurrence rate was 17,5 % with 248 relapses included in the study. An increase of 9.9, 5.7, and 5.7 times in the odds of relapse on the lymph node, peritoneum, and abdominal parenchymatous sites respectively was observed in case of nodal initial disease (p < 0.001). A not significant difference in odds was observed in terms of vaginal cuff relapse (OR 0.9) between lymph node ad uterine primary disease (p = 0.78). An increasing OR of 8.7 times for nodal recurrences, 46.6 times for peritoneum, and 23.3 times for parenchymatous abdominal recurrences were found in the case of primary peritoneal disease (p < 0.001).
CONCLUSION: Endometrial cancer tends to recur at the initial site of the disease. Intraoperative inspection of the adjacent sites of primary disease and targeted instrumental examination of the initial sites of disease during follow-up are strongly recommended.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 50(2024), 3 vom: 01. März, Seite 107985 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Capozzi, Vito Andrea [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Edometrial cancer |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejso.2024.107985 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367909014 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367909014 | ||
| 003 | DE-627 | ||
| 005 | 20240311232212.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240202s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2024.107985 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1323.xml |
| 035 | |a (DE-627)NLM367909014 | ||
| 035 | |a (NLM)38301532 | ||
| 035 | |a (PII)S0748-7983(24)00037-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Capozzi, Vito Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pattern of recurrence in endometrial cancer. The murderer always returns to the scene of the crime |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 11.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. | ||
| 520 | |a BACKGROUND: Endometrial cancer recurrence occurs in about 18 % of patients. This study aims to analyze the pattern recurrence of endometrial cancer and the relationship between the initial site of primary disease and the relapse site in patients undergoing surgical treatment | ||
| 520 | |a METHODS: We retrospectively reviewed all surgically treated patients with endometrial cancer selecting those with recurrence. We defined primary site disease as uterus, lymph nodes, or peritoneum according to pathology analysis of the surgical specimen. The site of recurrence was defined as vaginal cuff, lymph nodes, peritoneum, and parenchymatous organs. Our primary endpoint was to correlate the site of initial disease with the site of recurrence | ||
| 520 | |a RESULTS: The study enrolled 1416 patients. The overall recurrence rate was 17,5 % with 248 relapses included in the study. An increase of 9.9, 5.7, and 5.7 times in the odds of relapse on the lymph node, peritoneum, and abdominal parenchymatous sites respectively was observed in case of nodal initial disease (p < 0.001). A not significant difference in odds was observed in terms of vaginal cuff relapse (OR 0.9) between lymph node ad uterine primary disease (p = 0.78). An increasing OR of 8.7 times for nodal recurrences, 46.6 times for peritoneum, and 23.3 times for parenchymatous abdominal recurrences were found in the case of primary peritoneal disease (p < 0.001) | ||
| 520 | |a CONCLUSION: Endometrial cancer tends to recur at the initial site of the disease. Intraoperative inspection of the adjacent sites of primary disease and targeted instrumental examination of the initial sites of disease during follow-up are strongly recommended | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Edometrial cancer | |
| 650 | 4 | |a Lymph node | |
| 650 | 4 | |a Metastasis | |
| 650 | 4 | |a Peritoneum | |
| 650 | 4 | |a Recurrence | |
| 650 | 4 | |a Vaginal cuff | |
| 700 | 1 | |a Monfardini, Luciano |e verfasserin |4 aut | |
| 700 | 1 | |a Maglietta, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Barresi, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a De Finis, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Rosati, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Vargiu, Virginia |e verfasserin |4 aut | |
| 700 | 1 | |a Cosentino, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Sozzi, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Chiantera, Vito |e verfasserin |4 aut | |
| 700 | 1 | |a Bogani, Giorgio |e verfasserin |4 aut | |
| 700 | 1 | |a Carnelli, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Scambia, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Fanfani, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Ghi, Tullio |e verfasserin |4 aut | |
| 700 | 1 | |a Berretta, Roberto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology |d 1993 |g 50(2024), 3 vom: 01. März, Seite 107985 |w (DE-627)NLM01262862X |x 1532-2157 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:107985 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejso.2024.107985 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 3 |b 01 |c 03 |h 107985 | ||